JOHNSON & JOHNSON - 02 Jul 2021 Form 4 Insider Report for CVRx, Inc. (CVRX)

Role: 10%+ Owner
Signature: Johnson & Johnson By: /s/ Matthew Orlando, Secretary
Issuer symbol: CVRX
Transactions as of: 02 Jul 2021
Net transactions value: $0
Form type: 4
Filing time: 02 Jul 2021, 16:59:47 UTC
Previous filing: 29 Jun 2021
Next filing: 14 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CVRX	Common Stock	Conversion of derivative security		+3,495,575			3,495,575	02 Jul 2021	By Johnson & Johnson Innovation - JJDC, Inc.	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Date	Underlying Class	Amount	Ownership	Footnotes
transaction	CVRX	Series D-2 Preferred Stock	Conversion of derivative security	$0	-4,032,259	-100%	$0.000000^*	02 Jul 2021	Common Stock	101,958	By Johnson & Johnson Innovation - JJDC, Inc.	F1, F2
transaction	CVRX	Series E-2 Preferred Stock	Conversion of derivative security	$0	-6,451,188	-100%	$0.000000^*	02 Jul 2021	Common Stock	163,123	By Johnson & Johnson Innovation - JJDC, Inc.	F1, F2
transaction	CVRX	Series F-2 Preferred Stock	Conversion of derivative security	$0	-7,587,828	-100%	$0.000000^*	02 Jul 2021	Common Stock	191,864	By Johnson & Johnson Innovation - JJDC, Inc.	F1, F2
transaction	CVRX	Series G Preferred Stock	Conversion of derivative security	$0	-48,068,690	-100%	$0.000000^*	02 Jul 2021	Common Stock	3,038,630	By Johnson & Johnson Innovation - JJDC, Inc.	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of preferred stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date. Shares of Series D-2 Preferred Stock, Series E-2 Preferred Stock and Series F-2 Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.025857287 and shares of Series G Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.0632143218 (in each case, subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the Common Stock.
F2	These securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person.

Content

Each share of preferred stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration. The preferred stock had no expiration date. Shares of Series D-2 Preferred Stock, Series E-2 Preferred Stock and Series F-2 Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.025857287 and shares of Series G Preferred Stock converted into shares of Common Stock at a rate of 1-for-0.0632143218 (in each case, subject to the payment of cash in lieu of any fractional shares). The conversion rates reported reflect the conversion ratios under the Issuer's certificate of incorporation, adjusted to give effect to the previously effected 1-for-39.548 reverse stock split of the Common Stock.

These securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person.